Journal Mobile Options
Table of Contents
Vol. 14, No. 1, 2002
Issue release date: June 2002

Posterior Cortical Atrophy: Clinical Characteristics and Differences Compared to Alzheimer’s Disease

Mendez M.F. · Ghajarania M. · Perryman K.M.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Background: Predominant and progressive complex visual disorders are often due to posterior cortical atrophy (PCA), a rare early-onset dementing syndrome presenting with visual complaints. In clinicopathological studies, PCA is most commonly considered a form of Alzheimer’s disease (AD); no prior study has evaluated clinical differences between PCA and AD. Methods: This study identified 15 patients who presented with progressive complex visual disorders and predominant occipitoparietal hypoperfusion on SPECT. These patients were retrospectively compared on clinical variables with 30 patients with clinically probable AD matched for gender, age and duration of illness. Results: The PCA patients presented with alexia, elements of Balint’s syndrome, apperceptive visual agnosia, dressing apraxia and environmental disorientation along with elements of Gerstmann’s syndrome. Compared to the AD patients, the 15 PCA patients (mean age of onset 58 years, range 51–64) had significantly better verbal fluency, less memory difficulty, more depression and greater insight into their illness but similar familial and apolipoprotein E risk factors. In the PCA patients, MRI often showed occipitoparietal atrophy without detectable mesiotemporal atrophy. Conclusions: PCA is a distinct clinical syndrome and not just AD with prominent visual deficits. Compared to AD controls, PCA patients have better language and memory but more insight and depression and more posterior atrophy on MRI. These results indicate clinical criteria for the diagnosis of PCA and recommend specific interventions such as visual aids and antidepressant medications. Similar risk factors and course suggest that PCA is most commonly an early-onset posteriorly shifted AD variant.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Benson DF, Davis RJ, Snyder BD: Posterior cortical atrophy. Arch Neurol 1988;45:789–793.
  2. Victoroff J, Ross GW, Benson DF, Verity A, Vinters HV: Posterior cortical atrophy: Neuropathological correlations. Arch Neurol 1994;51:269–274.
  3. Pantel J, Schroder J: ‘Posterior cortical atrophy’ – Ein neues Demenzsyndrom oder Sonderform des Morbus Alzheimer? Fortschr Neurol Psychiatrie 1996;64:492–508.
  4. Galton CJ, Patterson K, Xuereb JH, Hodges JR: Atypical and typical presentations of Alzheimer’s disease: A clinical, neuropsychological, neuroimaging and pathological study of 13 cases. Brain 2000;123:483–498.
  5. Aharon-Peretz J, Israel O, Goldsher D, Peretz A: Posterior cortical atrophy variants of Alzheimer’s disease. Dement Geriatr Cogn Disord 1999;10:483–487.
  6. Ardila A, Rosselli M, Arvizu L, Kuljis RO: Alexia and agraphia in posterior cortical atrophy. Neuropsychiatry Neuropsychol Behav Neurol 1997;10:52–59.
  7. Freedman L, Costa L: Pure alexia and right hemiachromatopsia in posterior dementia. J Neurol Neurosurg Psychiatry 1992;55:500–502.
  8. Cogan DG: Visual disturbances with focal progressive dementing disease. Am J Ophthalmol 1985;100:68–72.

    External Resources

  9. Tom T, Cummings JL, Pollak J: Posterior cortical atrophy: Unique features. Neurocase 1998;4:15–20.
  10. Mendez MF, Cherrier MM: The evolution of alexia and simultanagnosia in posterior cortical atrophy. Neuropsychiatry Neuropsychol Behav Neurol 1998;11:1–7.
  11. Freedman L, Selchen DH, Black SE, Kaplan R, Garnett ES, Nahmias C: Posterior cortical dementia with alexia: Neurobehavioural, MRI, and PET findings. J Neurol Neurosurg Psychiatry 1991;54:443–448.
  12. Levine DN, Lee JM, Fisher CM: The visual variant of Alzheimer’s disease: A clinicopathological case study. Neurology 1993;43:305–313.
  13. Wakai M, Honda H, Takahashi A, Kato T, Ito K, Hamanaka T: Unusual findings on PET study of a patient with posterior cortical atrophy. Acta Neurol Scand 1994;89:458–461.
  14. Hof PR, Bouras C, Constantinidis J, Morrison JH: Selective disconnection of specific visual association pathways in cases of Alzheimer’s disease presenting with Balint’s syndrome. J Neuropathol Exp Neurol 1990;49:168–184.
  15. Mendez MF, Mendez MA, Martin R, Smyth KA, Whitehouse PJ: Complex visual disturbances in Alzheimer’s disease. Neurology 1990;40:439–443.
  16. Masterman DL, Mendez MF, Fairbanks LA, Cummings JL: Sensitivity, specificity and positive predictive value of technetium-99-HMPAO SPECT in discriminating Alzheimer’s disease patients from other dementias. J Neuropsychiatry Clin Neurosci 1997;10:15–21.
  17. Pietrini P, Furey ML, Graff-Radford N, Freo U, Alexander GE, Grady CL, Dani A, Mentis MJ, Schapiro MB: Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer’s disease: Clinical implications. Am J Psychiatry 1996;153:1261–1268.
  18. Goodglass H, Kaplan E: The Assessment of Aphasia and Related Disorders. Philadelphia, Lea and Febiger, 1976.
  19. Lezak MD: Neuropsychological Assessment, ed 3. New York, Oxford University Press, 1995.
  20. Mendez MF, Cherrier MM, Cymerman J: Hemispatial neglect on visual search tasks in Alzheimer’s disease. Neuropsychiatry Neuropsychol Behav Neurol 1997;10:203–208.
  21. Cummings JL, Benson DF, Hill MA, Read S: Aphasia in dementia of the Alzheimer type. Neurology 1985;35:394–397.

    External Resources

  22. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 1984;34:939–944.
  23. Folstein MF, Folstein SE, McHugh PR: ‘Mini-mental state’: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
  24. Hughes CP, Berg L, Danzinger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566–572.
  25. Welsh KA, Butters N, Mohs RC, Beekly D, Edland S, Fillenbaum G, Heyman A: The Consortium to Establish a Registry in Alzheimer’s Disease (CERAD). V. A normative study of the neuropsychological battery. Neurology 1994;44:609–614.
  26. Kiernan RJ, Mueller J, Langston JW, Van Dyke C: The Neurobehavioral Cognitive Status Examination: A brief differentiated approach to cognitive assessment. Ann Intern Med 1987;107:481–485.
  27. Wahlund L-O, Julin P, Johansson S-E, Scheltens Ph: Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: A comparative study. J Neurol Neurosurg Psychiatry 2000;69:630–635.

    External Resources

  28. Scheltens Ph, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, Kuiper M, Steinling M, Wolters EC, Valk J: Atrophy of medial temporal lobes on MRI in ‘probable’ Alzheimer’s disease and normal ageing: Diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 1992;55:967–972.
  29. Ross SJ, Graham N, Stuart-Green L, Prins M, Xuereb J, Patterson K, Hodges JR: Progressive biparietal atrophy: An atypical presentation of Alzheimer’s disease. J Neurol Neurosurg Psychiatry 1996;61:388–395.
  30. Beversdorf DQ, Heilman KM: Progressive ventral posterior cortical degeneration presenting as alexia for music and words. Neurology 1998;50:657–659.
  31. Mizuno M, Sartori G, Liccione D, Battelli L, Campo R: Progressive visual agnosia with posterior cortical atrophy. Clin Neurol Neurosurg 1996;98:176–178.
  32. Polk M, Kertesz A: Music and language in degenerative disease of the brain. Brain Cogn 1993;22:98–117.
  33. Graff-Radford NR, Bolling JP, Earnest F, Shuster EA, Caselli RJ, Brazis PW: Simultanagnosia as the initial sign of degenerative dementia. Mayo Clin Proc 1993;68:955–964.
  34. Berthier ML, Leiguarda R, Starkstein SE, Sevlever G, Taratuto AL: Alzheimer’s disease in a patient with posterior cortical atrophy. J Neurol Neurosurg Psychiatry 1991;54:1110–1111.
  35. Delamont RS, Harrison J, Field M, Boyle RS: Posterior cortical atrophy Clin Exp Neurol 1989;26:225–227.
  36. De Renzi E: Slowly progressive visual agnosia or apraxia without dementia. Cortex 1986;22:171–180.

    External Resources

  37. Hof PR, Archin N, Osmand AP, Dougherty JH, Wells C, Bouras C, Morrison JH: Posterior cortical atrophy in Alzheimer’s disease: Analysis of a new case and re-evaluation of a historical report. Acta Neuropathol 1993;86:215–223.

    External Resources

  38. Kiyosawa M, Bosley TM, Chawluk J, Jamieson D, Schatz NJ, Savino PJ, Sergott RC, Reivich M, Alavi A: Alzheimer’s disease with prominent visual symptoms: Clinical and metabolic evaluation. Ophthalmology 1989;96:1077–1086.

    External Resources

  39. Mangagi G, Bettoni L, Mazzucchi A: Lesioni atrofiche bioccipitali di incerta natura all’origine di una agnosia visiva. Riv Neurol 1982;52:137–148.

    External Resources

  40. Neary D, Snowden JS: Perceptuospatial disorders in Alzheimer’s disease. Semin Ophthalmol 1987;2:151–158.
  41. Otsuki M, Soma Y, Tanaka M, Tanaka K, Tanno Y, Uesugi Y, Tsuji S: Familial posterior cortical atrophy with visual agnosia and Balint’s syndrome. No To Shinkei 1995;47:1185–1190.
  42. Rogelet P, Delafosse A, Destee A: Posterior cortical atrophy: Unusual feature of Alzheimer’s disease. Neurocase 1996;2:495–501.

    External Resources

  43. Iizuka O, Soma Y, Otsuki M, Endo K, Tanno Y, Tsuji S: Posterior cortical atrophy with incomplete Balint’s syndrome. No To Shinkei 1997;49:841–845.
  44. Perez FM, Tunkel RS, Lachmann EA, Nagler W: Balint’s syndrome arising from bilateral posterior cortical atrophy or infarction: Rehabilitation strategies and their limitation. Disabil Rehabil 1996;18:300–304.
  45. Zarranz JJ, Lasa A, Fernandez M, Lezcano E, Perez Bas M, Varona L, Ruiz J, Beristain X: Atrofia cortical posterior con agnosia visual progresiva. Neurologia 1995;10:119–126.
  46. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, et al: Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer’s disease. Neurology 1993;43:1467–1474.
  47. Ala TA, Frey WH, Clark HB: Posterior cortical atrophy: Neuropathological correlations. Arch Neurol 1996;53:958.
  48. Hof PR, Vogt BA, Bouras C, Morrison JH: Atypical form of Alzheimer’s disease with prominent posterior cortical atrophy: A review of lesion distribution and circuit disconnection in cortical visual pathways. Vision Res 1997;37:3609–3625.

    External Resources

  49. Kobayashi S, Hirota N, Saito K, Utsuyama M: Aluminum accumulation in tangle-bearing neurons of Alzheimer’s disease with Balint’s syndrome in a long-term aluminum refiner. Acta Neuropathol (Berl) 1987;74:47–52.

    External Resources

  50. Kropp S, Schulz-Schaeffer WJ, Finkenstaedt M, Riedemann C, Windl O, Steinhoff BJ, Zerr I, Kretzschmar HA, Poser S: The Heidenhain variant of Creutzfeldt-Jakob disease. Arch Neurol 1999;56:55–61.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50